Clinical Trials · NCT03940235
Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsis
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- European Institute of Oncology
- Enrollment
- 150
- Start date
- Oct 2019
- Locations
- 1 site, Italy
- Primary endpoint
- Progression-free survival (PFS)